SEC Form 4 · accession 0001628280-16-019572

CHAMPIONS ONCOLOGY, INC. · CSBR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Joel Ackerman

Officer — Chief Executive Officer · Director

Period of report

Jul 21, 2016

Accepted (ET)

Sep 14, 2016 · 4:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000771856

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Common Stock^F2,F1	$2.10	Jul 21, 2016	A	150,795	A	—	Oct 25, 2025	Common Stock	150,795	150,795	D
Option to purchase Common Stock^F2,F1	$2.10	Jul 21, 2016	A	150,795	A	—	Oct 25, 2025	Common Stock	150,795	150,795	D
Option to purchase Common Stock^F2,F3	$2.10	Jul 21, 2016	A	101,521	A	—	Nov 5, 2023	Common Stock	101,521	101,521	D
Option to purchase Common Stock^F2,F4	$2.10	Jul 21, 2016	A	101,521	A	—	Nov 5, 2023	Common Stock	101,521	101,521	D
Option to purchase Common Stock^F2,F1	$2.10	Jul 21, 2016	A	14,552	A	—	Nov 5, 2023	Common Stock	14,552	14,552	D
Option to purchase Common Stock^F2,F1	$2.10	Jul 21, 2016	A	88,470	A	—	Nov 1, 2024	Common Stock	88,470	88,470	D
Option to purchase Common Stock^F2,F5	$2.10	Jul 21, 2016	A	94,405	A	—	Nov 1, 2025	Common Stock	94,405	94,405	D
Option to purchase Common Stock^F2,F6	$4.92	Jul 21, 2016	D	182,580	D	—	Oct 25, 2020	Common Stock	182,580	0	D
Option to purchase Common Stock^F2,F4	$4.92	Jul 21, 2016	D	182,580	D	—	Oct 25, 2020	Common Stock	182,580	0	D
Option to purchase Common Stock^F2,F7	$4.92	Jul 21, 2016	D	112,331	D	—	Nov 5, 2023	Common Stock	112,331	0	D
Option to purchase Common Stock^F2,F4	$4.92	Jul 21, 2016	D	112,331	D	—	Nov 5, 2023	Common Stock	112,331	0	D
Option to purchase Common Stock^F2,F6	$4.92	Jul 21, 2016	D	16,101	D	—	Nov 5, 2023	Common Stock	16,101	0	D
Option to purchase Common Stock^F2,F6	$4.92	Jul 21, 2016	D	96,283	D	—	Nov 1, 2024	Common Stock	96,283	0	D
Option to purchase Common Stock^F2,F8	$4.55	Jul 21, 2016	D	100,765	D	—	Nov 1, 2025	Common Stock	100,765	0	D

Explanation of responses

F1Fully vested upon grant.
F2The reporting person agreed to the cancellation of options granted to him on March 16, 2015 and November 19, 2015 in exchange for new options having a lower exercise price.
F3Vested as to 74,529 shares on grant; remainder to vest on November 5, 2016.
F4Vesting to occur upon completion of performance criteria that have not been set.
F5Vested as to 70,804 shares on grant; remainder to vest on October 31, 2016.
F6Fully Vested.
F7Vested as to 84,249 shares on grant; remainder to vest on November 5, 2016.
F8Vested as to 75,574 shares on grant; remainder to vest on October 31, 2016.